Efgartigimod for the Treatment of Guillain-Barré Syndrome

Clinical trial NCT06885762 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06885762
Sponsor: Zhongming Qiu
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Guillain-Barre Syndrome (GBS)

Start date: 2025-04-13
Primary completion: 2026-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.